THE EFFECT OF VIRUSES ON BLOOD TRANSFUSION IN REGIONAL BLOOD BANK IN HAFAR ALBATIN
Main Article Content
Keywords
effect of viruses, blood transfusion, Hafr Al-Batin blood bank
Abstract
The fact that blood groups can act as receptors/coreceptors for bacteria, viruses, and parasites demonstrates the importance of blood groups in infection. Blood group antigens also aid in cell adsorption, signal transmission, and/or membrane micro-domain retention. Furthermore, blood type can influence the innate immune response to infection. This data was compiled using the risk perception of blood transfusion scale, which is part of a larger risk perception questionnaire. Blood transfusion risk perception is measured on a 7-point Likert scale based on a set of qualitative characteristics; 119 participants in Hafr Al-Batin blood bank had a significant difference in risk perception of blood transfusion due to receiving blood, whereas those who had never received blood had no risk perception. as much risk perception of blood transfusion, and because of viral hepatitis infection, those who did not have viral hepatitis had more risk perception of blood transfusion, but there is no significant difference in risk perception of blood transfusion due to gender, age, educational level, and blood donation. The implementation of strict donor pre-screening and preventative measures to control infections in the general population, as well as the introduction of new, more sensitive screening tests, could significantly reduce transfusion-transmitted viral infections across eastern Saudi Arabia.
References
2. Reid, M. E., Lomas-Francis, C., & Olsson, M. L. (2012). Blood group antigen Facts Book, 3rd ed Academic Press, Waltham, MA.
3. Burton, N. M., & Bruce, L. J. (2011). Modelling the structure of the red cell membrane. Biochemistry and cell biology, 89(2), 200-215. doi: 10.1139/O10-154.
4. An, X., & Mohandas, N. (2008). Disorders of red cell membrane. British journal of haematology, 141(3), 367-375. doi: 10.1111/j.1365-2141.2008.07091. x.
5. Hosseini, S. M., & Feng, J. J. (2012). How malaria parasites reduce the deformability of infected red blood cells. Biophysical journal, 103(1), 1-10. doi: 10.1016/j.bpj.2012.05.026.
6. Falusi, A. G., Ademowo, O. G., Latunji, C. A., Okeke, A. C., Olatunji, P. O., Onyekwere, T. O., ... & Itata, E. O. (2000). Distribution of ABO and RH genes in Nigeria. African journal of medicine and medical sciences, 29(1), 23-26.
7. Hawkins, B. R., & Simons, M. J. (1976). Blood group genetic studies in an urban Chinese population. Human heredity, 26(6), 441-453. Achermann, F. J., Julmy, F., Gilliver, L. G., Carrel,
T. P., & Nydegger, U. E. (2005). Soluble type A substance in fresh-frozen plasma as a function of ABO and Secretor genotypes and Lewis phenotype. Transfusion and apheresis science, 32(3), 255-262. 5. doi: 10.1016/j.transci.2004.05.007.
8. Rodak, B. F., Frisma, G. A., & Keohane, E. M. (2012). Hematology: Clinical principles and applications. 4th ed. Missouri: Elesevier; p1-6.
9. Coban, E., Ozdogan, M., Yazicioglu, G., & Akcit, F. (2005). The mean platelet volume in patients with obesity. International journal of clinical practice, 59(8), 981-982.
10. Chu, S. G., Becker, R. C., Berger, P. B., Bhatt, D. L., Eikelboom, J. W., Konkle, B., ... & Berger, J. S. (2010). Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐ analysis. Journal of Thrombosis and Haemostasis, 8(1), 148-156.
11. Dantzer, R., & Kelley, K. W. (2007). Twenty years of research on cytokine-induced sickness behavior. Brain, behavior, and immunity, 21(2), 153-160.
12. Shanahan, L., Bauldry, S., Freeman, J., & Bondy, C. L. (2014). Self-rated health and C-reactive protein in young adults. Brain, behavior, and immunity, 36, 139-146.
13. Koh, J. M., Khang, Y. H., Jung, C. H., Bae, S., Kim, D. J., Chung, Y. E., & Kim, G. S. (2005). Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre-and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporosis International, 16(10), 1263-1271.
14. Amin, M., Wilson, K., Tinmouth, A., & Hébert, P. (2004). Does a perception of increased blood safety mean increased blood transfusion? An assessment of the risk compensation theory in Canada. BMC Public health, 4(1), 1-4.
15. Ngo, L. T., Bruhn, R., & Custer, B. (2013). Risk perception and its role in attitudes toward blood transfusion: a qualitative systematic review. Transfusion medicine reviews, 27(2), 119- 128.
16. Evatt, B. (2006, April). Infectious disease in the blood supply and the public health response. In Seminars in hematology (Vol. 43, pp. S4-S9). WB Saunders.
17. Vamvakas, E. C., & Blajchman, M. A. (2010). Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality. Transfusion medicine reviews, 24(2), 77- 124.
18. Vamvakas, E. C., & Blajchman, M. A. (2009). Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood, The Journal of the American Society of Hematology, 113(15), 3406-3417.
19. Martínez-González, N. A., Tandjung, R., Djalali, S., Huber-Geismann, F., Markun, S., & Rosemann, T. (2014). Effects of physician-nurse substitution on clinical parameters: a systematic review and meta-analysis. PloS one, 9(2), e89181.
20. Mundinger, M. O., Kane, R. L., Lenz, E. R., Totten, A. M., Tsai, W. Y., Cleary, P. D., ... & Shelanski, M. L. (2000). Primary care outcomes in patients treated by nurse practitioners or physicians: a randomized trial. Jama, 283(1), 59- 68.
21. Vetter, T. R., Adhami, L. F., Porterfield Jr, J. R., & Marques, M. B. (2014). Perceptions about blood transfusion: a survey of surgical patients and their anesthesiologists and surgeons. Anesthesia & Analgesia, 118(6), 1301-1308.
22. Slovic, P. (1987). Perception of risk. Science, 236(4799), 280-285.
23. Ferguson, E., Farrell, K., Lowe, K. C., & James, V. (2001). Perception of risk of blood transfusion: knowledge, group membership and perceived control. Transfus Med, 11(2), 129–35.
24. Lee, D. H., Mehta, M. D., & James, P. D. (2003). Differences in the perception of blood transfusion risk between laypeople and physicians. Transfusion, 43(6), 772-778.
25. World Health Organisation. Timeline: WHO's COVID-19 response. Published July 2020. [Accessed on: 23/12/2021]. Available from: https://www.who.int/emergencies/diseases/ novel- coronavirus-2019/interactive-timeline/#!
26. Ministry of Home Affairs. Government of India. Notifications: Circulars for COVID-19. [Accessed on: 05/01/ 2021]. Available from: http://www.mha.gov.in/notifications/circular
27. Arcot, P. J., Kumar, K., Mukhopadhyay, T., & Subramanian, A. (2020). Potential challenges faced by blood bank services during COVID-19 pandemic and their mitigative measures: The Indian scenario. Transfusion and Apheresis Science, 59(5), 102877. https://doi.org/10.1016/ j. transci.2020.102877.
28. Dhiman, Y., Patidar, G. K., & Arora, S. (2020). Covid‐19 pandemic‐response to challenges by blood transfusion services in India: a review report. ISBT Science series, 15(4), 365-373.
29. National Aids Control Organisation. A Report on the Assessment of Blood Banks in India 2016. National Aids Control Organisation, Ministry of Health and Family Welfare, Government of India. [Accessed on 30/09/2021]. Available from: http://naco.gov.in/sites/default/files/ Assessment%2 0of%20Blood%20Banks%20in%20India%20- %202016.pdf.
30. Basavarajegowda, A., Usha, K. C., & Mayadevi, S. (2020). Self-admitted motivating factors and barriers to blood donation in a single center from Southern India. Global Journal of Transfusion Medicine, 5(1), 34-37.
31. Khuroo, M. S., Khuroo, M. S., & Khuroo, N. S. (2016). Transmission of hepatitis E virus in developing countries. Viruses, 8(9), 253. doi:10.3390/v809025310.
32. Hewitt, P. E., Ijaz, S., Brailsford, S. R., Brett, R., Dicks, S., Haywood, B., & Tedder, R. S. (2014).Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. The Lancet, 384(9956), 1766-1773. doi:10.1016/S0140- 6736(14)61034-58
33. Khuroo, M. S., Kamili, S., & Yattoo, G. N. (2004). Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. Journal of gastroenterology and hepatology, 19(7), 778-784. doi:10.1111/j.1440- 1746.2004.03437.x
34. Al‐Fawaz, I., Al‐Rasheed, S., Al‐Mugeiren, M., Al‐Salloum, A., Al‐Sohaibani, M., & Ramia, S. (1996). Hepatitis E virus infection in patients from Saudi Arabia with sickle cell anaemia and β‐ thalassemia major: possible transmission by blood transfusion. Journal of viral hepatitis, 3(4), 203- 205. doi:10.1111/j.1365-2893. 1996.tb00096.x
35. Hoad, V. C., Gibbs, T., Ravikumara, M., Nash, M., Levy, A., Tracy, S. L., ... & Bowden, S. (2017). First confirmed case of transfusion-transmitted hepatitis E in Australia. The Medical journal of Australia, 206(7), 289-290. doi:10.5694/mja16.01090
36. Chang, L., Yan, Y., & Wang, L. (2020). Coronavirus disease 2019: coronaviruses and blood safety. Transfusion medicine reviews, 34(2), 75-80. Cai, X., Ren, M., Chen, F., Li, L., Lei, H., & Wang, X. (2020). Blood transfusion during the COVID-19 outbreak. Blood Transfusion, 18(2), 79.
37. Hawkins, B. R., & Simons, M. J. (1976). Blood group genetic studies in an urban Chinese population. Human heredity, 26(6), 441-453. doi: 10.1159/000152839.
38. Yan, L., Zhu, F., Fu, Q., & He, J. (2005). ABO, Rh, MNS, Duffy, Kidd, Yt, scianna, and colton blood group systems in indigenous Chinese. Immunohematology, 21(1), 10-14.
39. Waheed, U., Wazeer, A., Saba, N., & Qasim, Z. (2020). Effectiveness of WhatsApp for blood donor mobilization campaigns during COVID-19 pandemic. ISBT Sci Ser, 15(04), 378-380. https://doi.org/ 10.1111/voxs.12572.